PT  - JOURNAL ARTICLE
AU  - Bailey, Clifford J.
AU  - Gavin, James R.
TI  - Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence
AID  - 10.2337/cd20-0076
DP  - 2020 Nov 24
TA  - Clinical Diabetes
PG  - cd200076
4099  - http://clinical.diabetesjournals.org/content/early/2020/11/22/cd20-0076.short
4100  - http://clinical.diabetesjournals.org/content/early/2020/11/22/cd20-0076.full
AB  - Optimizing glycemic control remains a shared challenge for clinicians and their patients with diabetes. Flash continuous glucose monitoring (CGM) provides immediate information about an individual’s current and projected glucose level, allowing users to respond promptly to mitigate or prevent pending hypoglycemia or hyperglycemia. Large randomized controlled trials (RCTs) have demonstrated the glycemic benefits of flash CGM use in both type 1 and type 2 diabetes. However, whereas RCTs are mostly focused on the efficacy of this technology in defined circumstances, real-world studies can assess its effectiveness in wider clinical settings. This review assesses the most recent real-world studies demonstrating the effectiveness of flash CGM use to improve clinical outcomes and health care resource utilization in populations with diabetes.